Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mi Ji Lee

Showing results (1-10 of 171) with videos related to

Pageof 18
Sort By:
The Lancet. Neurology|September 20, 2025
Revisiting candesartan: new evidence for an old option in migraine preventionMi Ji Lee
BMC Women'S Health|August 10, 2021
Maintenance of smoking cessation in Korean single mothersMi-Ji Lee, Kang-Sook Lee
Journal of Clinical Neurology (Seoul, Korea)|July 10, 2025
Real-World Experience of Lasmiditan for the Acute Treatment of MigraineHoe Jong Jeong, Mi Ji Lee
Cephalalgia : an International Journal of Headache|January 5, 2021
Board Walk - January 2021Henrik Winther Schytz, Mi Ji Lee
Cephalalgia : an International Journal of Headache|February 14, 2023
Other primary headaches: Distinct clinical features and uncertain pathophysiologyMi Ji Lee, Kuan-Po Peng
Cephalalgia : an International Journal of Headache|February 9, 2023
Epicranial headache part 1: Primary stabbing headacheSoonwook Kwon, Mi Ji Lee, Manho Kim
Headache|June 26, 2025
Early nimodipine treatment in reversible cerebral vasoconstriction syndrome: A serial transcranial Doppler studySoohyun Cho, Minjung Seong, Mi Ji Lee
Scientific Reports|September 8, 2023
Predictors of galcanezumab response in a real-world study of Korean patients with migraineSeung Ae Kim, Hyemin Jang, Mi Ji Lee
Frontiers in Neurology|July 6, 2019
Effect of Nimodipine Treatment on the Clinical Course of Reversible Cerebral Vasoconstriction SyndromeSoohyun Cho, Mi Ji Lee, Chin-Sang Chung
Cephalalgia : an International Journal of Headache|March 18, 2022
Real-world efficacy of galcanezumab for the treatment of migraine in Korean patientsSoonwook Kwon, Young-Eun Gil, Mi Ji Lee
Pageof 18

Showing results (1-10 of 171) with videos related to

Sort By:
Pageof 18
The Lancet. Neurology|September 20, 2025
Revisiting candesartan: new evidence for an old option in migraine preventionMi Ji Lee
BMC Women'S Health|August 10, 2021
Maintenance of smoking cessation in Korean single mothersMi-Ji Lee, Kang-Sook Lee
Journal of Clinical Neurology (Seoul, Korea)|July 10, 2025
Real-World Experience of Lasmiditan for the Acute Treatment of MigraineHoe Jong Jeong, Mi Ji Lee
Cephalalgia : an International Journal of Headache|January 5, 2021
Board Walk - January 2021Henrik Winther Schytz, Mi Ji Lee
Cephalalgia : an International Journal of Headache|February 14, 2023
Other primary headaches: Distinct clinical features and uncertain pathophysiologyMi Ji Lee, Kuan-Po Peng
Cephalalgia : an International Journal of Headache|February 9, 2023
Epicranial headache part 1: Primary stabbing headacheSoonwook Kwon, Mi Ji Lee, Manho Kim
Headache|June 26, 2025
Early nimodipine treatment in reversible cerebral vasoconstriction syndrome: A serial transcranial Doppler studySoohyun Cho, Minjung Seong, Mi Ji Lee
Scientific Reports|September 8, 2023
Predictors of galcanezumab response in a real-world study of Korean patients with migraineSeung Ae Kim, Hyemin Jang, Mi Ji Lee
Frontiers in Neurology|July 6, 2019
Effect of Nimodipine Treatment on the Clinical Course of Reversible Cerebral Vasoconstriction SyndromeSoohyun Cho, Mi Ji Lee, Chin-Sang Chung
Cephalalgia : an International Journal of Headache|March 18, 2022
Real-world efficacy of galcanezumab for the treatment of migraine in Korean patientsSoonwook Kwon, Young-Eun Gil, Mi Ji Lee
Pageof 18